Clinical Trials Browser

Phase 1/2 × OTHER × Clinical Trials, Phase I as Topic × Clear all

Small Cell Lung Carcinoma

NCT02223208 2025-12-02

FIL_PTCL13

Phase 1/2 Active not recruiting

89 enrolled

Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Peripheral

NCT06839456 2025-03-25

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

Phase 1/2 Recruiting

100 enrolled

Classical hematologyLymphoidOther hematologic neoplasm

Bone Marrow Failure Disorders, Congenital Bone Marrow Failure Syndromes, Anemia, Refractory, with Excess of Blasts, Hemoglobinopathies, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Non-Hodgkin, Metabolism, Inborn Errors

NCT02382406 2023-05-23

Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC

Phase 1/2 Terminated

46 enrolled 24 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00547339 2022-12-07

Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer

Phase 1/2 Completed

94 enrolled 14 charts

Genitourinary

Prostatic Neoplasms

Clinical Trials

PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

FIL_PTCL13

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC

Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer